The capacity of angiogenin (Ang) to induce blood vessel growth is critically dependent on its ribonucleolytic activity. Crystallography and mutagenesis of human Ang have previously shown that its pyrimidine binding site is obstructed by Gln-117, implying that a conformational change is a key part of the mechanism of Ang action. The
Angiogenin (Ang) is unique among angiogenic molecules in that it is a member of the pancreatic ribonuclease (RNase) superfamily (1) and, in fact, is a ribonucleolytic enzyme (2) . Its enzymatic activity is extremely weak compared to that of the digestive RNases (2, 3) but is critical for its capacity to induce neovascularization (4, 5) . Its in vivo substrate remains to be identified.
Ang was first isolated from human tumor cell conditioned medium (6) and subsequently from normal human plasma (7) . Angs have also been purified from other mammalian sera (8, 9) and from cow's milk (10) . Most previous efforts to elucidate the structural basis for and relationship between enzymatic and angiogenic activities have focused on human Ang (hAng). Mutagenesis, proteolysis, and chemical modification studies have thus far identified several residues that play important or essential roles in catalysis or substrate binding and have at least part#Haccounted for the enzymatic differences between Ang and pancreatic RNase (4, 5, (11) (12) (13) . Moreover, they have demonstrated that angiogenic activity requires not only an intact catalytic site but also another region of Ang, thought to constitute a cell binding site.
Recently, hAng has been crystallized (14) and a 2.4-Aresolution structure has been determined (15) , which provides a basis for the unique functional properties of the protein.
Most strikingly, it reveals that the site corresponding to the pyrimidine binding pocket of RNase A is blocked by Gln-117. Mutations of this residue to Ala and Gly increase enzymatic activity (16) , implying that this conformation for Ang also exists in solution. The structure of native Ang in which access to the binding site is blocked presumably must undergo extensive reorientation in order to allow binding and cleavage of RNA. This conformational change might also serve to activate Ang at its target site in vivo.
In continuing efforts to further understand the structurefunction relationships of Ang, we have now determined the x-ray structure of bovine angiogenin (bAng). This protein (Mr 14,595) has 64% sequence identity to hAng (10) , virtually the METHODS bAng was isolated from unpasteurized milk essentially as described for its purification from plasma (8) . Needle-shaped crystals (maximum dimensions, 0.7 mm x 0.3 mm x 0.3 mm) were grown at 16°C using the hanging drop method with a reservoir solution of 0.1 M sodium acetate/0.2 M ammonium acetate, pH 4.5/30% polyethylene glycol 4000. They belong to the orthorhombic space group P212121 (a = 30.69 A, b = 54.45 A, c = 74.75 A) with one molecule per asymmetric unit and 43% (vol/vol) solvent content. Diffraction data (AD-lab data set) were collected from native crystals (1.6 A) using a Siemens area detector mounted on a Siemens rotating anode x-ray source using CuKa radiation (50 kV, 80 mA). Overall, 1900 frames of data were collected (0.25°per frame; crystal to detector distance, 10 cm; 20 angle, 350; 120-130 sec per frame exposure). The data were processed using the XDS package (17) . Higher-resolution data to 1.5 A (SRS data set) were collected on station 9.5 of the Synchrotron Radiation Source (SRS; Daresbury, U.K.), using an 18-cm (diameter) MARresearch imaging plate system with an x-ray beam of 0.88-A wavelength (0.2-mm collimator) from one crystal with 1.50 oscillations. The SRS data were processed using the MOSFLM package (A. Leslie, Medical Research Council, Cambridge, U.K.). The two data sets were scaled by using the program 3DSCALE (18) ( Table 1 ). The structure was determined using the MERLOT molecular replacement programs (19) and the search was based on the hAng protein model (15) with bAng amino acid sequence changes incorporated into the model. The angles from rotation and translation function search gave a single, self-consistent set of translation vectors on the Harker sections. Cycles of positional and simulated annealing refinement using the X-PLOR package (20) and model building using FRODO (21) The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
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Biochemistry: Acharya et al 2or, and F > 3cr, respectively; rms deviation of bond lengths from ideality, 0.008 A; bond angles, 1.53°). The structure contains 91 bound water molecules. All non-glycine residues lie within the allowed regions of the Ramachandran (4, qi) plot.
Individual temperature factors were refined for each atom during the final stages of refinement (the mean temperature factor for protein atoms is 19.8 A2).
RESULTS AND DISCUSSION
Overall Structure. In general, the electron density map is of high quality ( Fig. 1 ) and the entire structure is well-defined except for the three N-terminal residues, the four C-terminal residues, the side chains of Asp-60 and Arg-61, and the terminal portions of the side chains of Lys-20, Lys-83, Arg-90, and Arg-102, all of which have high temperature factors and are disordered. The structure of bAng has the "RNase A fold" (Fig. 2 ) and is very similar to that of hAng (15) . most significantly are the N-terminal residues 2 and 3 (5.16 and 2.47 A, respectively) and the C-terminal residues 120-122 (1.65, 5.07, and 9.54 A, respectively). The difference in the C-terminal region is particularly noteworthy as discussed below. In hAng, residues 117-121 form a 310 helix that is absent in bAng; instead, the corresponding segment appears to be flexible and disordered after the second residue, Ser-119. The amino acid sequence in this segment is also poorly conserved between the two Angs. Exclusion of these residues and amino acids 2 and 3 from the structural comparison reduces the rms deviation in Cc positions for the two proteins to 0.51 A, indicating a high degree of similarity between the structures.
Only five residues (21, 50, 68, 88 , and 89) differ in position by >1.0 A. All but one of these (Asn-50) are on a loop. Two peptide bonds in the bAng crystal structure adopt a cis conformation: those connecting Arg-38 with Pro-39 and Pro-91 with Pro-92. Both bonds are also cis in the hAng structure (1ANG-PDB).
Pyrimidine Binding Site B1. The major, unexpected feature of the hAng crystal structure was the finding that Gln-117 blocks the site that is spatially analogous to the B1 pyrimidine binding pocket of RNase A. The same obstruction is seen for the corresponding residue, Glu-118, in bAng (Fig. 4) . This is more dramatically evident when the inhibitor uridine vanadate is superimposed onto the B1 site of bAng by modeling (Fig. 5 Left): the Glu side chain is seen to pass through the uracil ring. The substitution of Gln by Glu in bAng is conservative: both of the side-chain H bonds (to N and OG1 of Thr-45; Table 2 ) of the human protein are maintained. In addition, Glu-118 is held in place by H bonds from its main-chain C=O and side-chain OEI to Arg-43 (NH1 and NE, respectively). In hAng Arg-43 is replaced by Ile-42, which is not close to Biochemistry: Acharya et al during its normal catalytic pathway, a view that is further supported by the results of mutagenesis and modeling studies on hAng (16) . Information from both Ang x-ray structures is pertinent to this issue. In RNase A, Thr-45, Ser-123, and Phe-120 in RNase A have been proposed to interact with the pyrimidine moiety in the B1 site, with the first two forming H bonds and the last making van der Waals or stacking contacts (see refs. 26 and 27). In both Angs, the corresponding Thr is positioned almost identically to Thr-45 in RNase and base specificity is similar to that of RNase. This would tend to rule out any substantial movement of this residue during the proposed conformational transition.
In contrast, Ser-119 of bAng and Ser-118 of hAng are positioned quite differently from Ser-123 of RNase A (Fig. 5) . Hence, neither one would be expected to be part of the B1 site. Consistent with this, mutations of Ser-118 in hAng do not alter specificity (5) . At the same time, these mutations decrease overall activity to some extent, suggesting a catalytic role, perhaps indirect, for Ser-118 once the B1 site has opened. This interpretation is not straightforward, however, since Ser-118(119) appears to help maintain the closed conformation by means of H bonds with Asp-116 (hAng)/Asp-117 (bAng) (ref. 15 and Table 2 ).
The replacement of Phe-120 in RNase A by Leu-115 in hAng has been thought to be another factor contributing to the lower enzymatic activity of Ang (28) . bAng, like RNase A, contains a Phe at this position in the sequence that is located similarly in the three-dimensional structure. However, its phenyl ring is rotated by nearly 900 with respect to that of Phe-120 in RNase (Fig. 5) ; thus, if it interacts productively with the pyrimidine when the B1 site opens, some reorientation would be required.
Catalytic Center (P1). The positions of the catalytic residues His-14, Lys-41, and His-115 in bAng are virtually identical to those of their counterparts in hAng and RNase A. Several interactions of these residues, not seen in the 2.4-A-resolution hAng structure, can now be identified in the higher-resolution bAng structure ( Fig. 4; Table 2 ). NZ of Lys-41 H bonds to OD1 of Asn-44 (as in RNase A) and interacts via water molecules with NE2 of Gln-13, NE2 of His-14, and OE2 of Glu-118. Numerous additional water molecules are found in this region. A water-mediated H bond that appeared to exist between His-114 and Asp-116 in hAng is clearly absent in bAng.
B2 Site. A B2 site for binding the base whose ribose donates its 5' oxygen to the scissile bond has not yet been defined in hAng. Recent results of mutagenesis (29) demonstrate that Asn-71 and Glu-111 are components of this site in RNase A.
The only potential H-bonding residues in the corresponding region of hAng are Asn-68 and Glu-108; mutagenesis indicates that Glu-108 plays only a minor role in activity (5), whereas the function of Asn-68 has not been examined as yet. This region differs significantly in bAng. Glu-109 is shifted somewhat from the position of Glu-108 in hAng and forms a H bond to NH2 of Arg-6 (2.83 A) that is absent in the human protein. in bAng replaces Asn-68 of hAng and deviates in orientation after the ,B-carbon (Fig. 6) . In this regard it should be noted that the base specificity of bAng and hAng at this position differs markedly: bAng prefers G over A by severalfold (M. D. Bond and R.S., unpublished results), whereas the inverse is true for hAng (3) .
Receptor Binding Site. Ang interacts with cultured vascular endothelial cells and elicits a number of responses that may be relevant to angiogenesis (30) (31) (32) . These effects are presumably mediated through binding of Ang to cellular-receptors. Mutagenesis, deamidation, and proteolysis studies on hAng indicate that the receptor binding site is distinct from the catalytic center and includes the segments 58-70 (loops 4 and 5 and 13-strands B2 and B3) and 108-111 (loop 9) (3, (11) (12) (13) .
[Interestingly, this region may also contain part of the B2 subsite for RNA binding in Ang, as does the corresponding region of RNase A (see above).] Asn-61, Arg-66, and Asn-109 are the specific residues implicated thus far; replacements of each abolish angiogenic activity but have no significant effect on enzymatic activity.
All three of these residues are conserved in the bAng sequence, as Asn-62, Arg-67, and Asn-110. The conformations of the segments containing these residues are generally very similar [the rms deviation in Cc, positions for residues 59-71 ( This segment of bAng includes an RGD sequence (residues 67-69), a motif known to be a recognition element in many integrin-dependent cell adhesion processes (33) . This motif is replaced by Arg-Glu-Asn in hAng and on this basis it has been proposed that the cellular interactions of the two proteins may differ (34) . Thus far, however, no experimental evidence supports such a difference. Indeed, the angiogenic activities of bAng and hAng are equivalent (8) and, although bovine endothelial cells adhere to bAng through integrins, this is also true for their adhesion to hAng (32) .
To examine this question in structural terms, we have compared the conformation of the RGD residues of bAng with those in two other proteins known to bind integrins, foot and mouth disease virus VP1 protein and yII-crystallin. The VP1 and yII-crystallin RGD structures are virtually identical (rms deviation for C" atoms, only 0.09 A) and differ markedly from RGD structures observed in proteins considered to lack integrin binding activity (e.g., xylose isomerase, thermolysin, tryptophan synthase, and a-lytic protease; rms deviations, 0.53-0.89 A) (see ref. 35) . Although the RGD sequence in bAng is located on an exposed loop, as are its VP1 and yII-crystallin counterparts, its structure is quite distinct (Fig. 7) (34) . The general fold observed is in agreement with that found in the crystalline state. Importantly, this similarity includes the C-terminal region, which is also disordered in the NMR structure.
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